±±¾©Ê¦·¶´óѧϸ°ûÉúÎïѧÊÔÌâÀúÄê»ã×Ü£¨²©Ê¿£©2001Äê-1990Äê(ȱ1997Äê,1998Äê) /2}o:vLj
Ò»¡¢ Ãû´Ê½âÊÍ£º #oRm-yDr
1£® ͬԴºÐ£¨homeobox£©£¨96¡¢99¡¢91£© dxqVZksg(9
2£® PCR£¨96£© sX&.8
3£® ·ºËØ£¨ubquitin£©£¨96£© ~
\= VSwJ
4£® °é·Ö×Ó£¨chapron£©£¨96£© s ^NO(
5£® ת¼Òò×Ó£¨trascription factor£©£¨96£© V3;4,^=6Dd
6£® DG£IP3£¨96£© F) w.
q
7£® »ùÒòÇóý£*****ene knock out£©£¨96¡¢00£© yXU-@~
8£® ΢¹Ü×éÖ¯ÖÐÐÄ£¨MTOC£©£¨96¡¢01£© A
?"(5da.
9£® ¶ËÁ£Ã¸£¨telomerase£©£¨96£© u\YH,
10£® µ°°×·ÖÑ¡£¨protein sorting£©£¨96¡¢99¡¢00£© }e3M5LI1L
11£® Transformation£¨92£© &`>[4D*
12£® TransfectionתȾ£¨92£© :}d`$2Dz
13£® Transcytosis×ªÒÆ×÷Óã¨92£© cBf9-k
14£® Transductionתµ¼£¨92£© M99#\0=/
15£® Transdetermination£¨92£© p:M#F:
16£® Transdifferentiation£¨92£© +EJwWD
J!%
17£® Transgenic animalת»ùÒò¶¯Î92£© }.Eq_wP<
18£® Rb£1£¨92£© J6x\_]1:*
19£® P53£¨92¡¢91£© _`lj
3Lm0>
20£® C£jun£¨92£© QX(x6y>Q
21£® ΢¹Û½áºÏµ°°×MAPS£¨99¡¢91£© d
q=>-^o
22£® °ûÄÚÌ壨99£© A^7!:^%K
23£® Cyclin dependent kinase inhibitor(CDKI)(99) 2mL1BG=Yk
24£® G£protein£¨91£© 4GJ1P2
25£® Restriction point£¨91£© zx^]3}
26£® Antipost£¨91£© A7U'>r_.
27£® Capping£¨91£© "cjZ6^Hum
28£® TATAbox£¨91£© H e]1<tx
29£® cDNA library£¨90£© eydVWVN
30£® Aritotic apparatus£¨90£© WujIaJt-
31£® ¿çĤÐźŠtransmembrane signal£¨90£© :1u>T3L.z
32£® ´ÙÓÐË¿·ÖÁÑÔ mitogen£¨90£© dJ\6m!Mp
33£® Nuclear lamina£¨90£© Rde
_I`Ru
34£® ϸ°ûµòÍö£¨apotosis£©£¨00£© ^B@4 w\t
35£® ϸ°ûÍâ»ùÖÊ£¨00¡¢01£© T#Pz_
hAu
36£® ϸ°û·Ö»¯£¨00£© hZnT`!iFE^
37£® ϸ°ûÐźÅתµ¼£¨signal transduction£©£¨00£© KsYT3
38£® ¿Ë¡£¨00£© I Vy,A7f
39£® »ùÒò×飨00£© `7jm
40£® Caspase£¨00£© "@B!5s0
41£® ת¼Òò×Ó£¨00£©
H%7V)"
42£® ÅßÌ¥¸Éϸ°û£¨01£© 7ka^y k@Q
43£® ¼¤¹â¹²¾Û½¹ÏÔ΢¾µ£¨01£© x
( w <U1
44£® DNAоƬ£¨01£© 6A M,1
¶þ¡¢ ÎÊ´ðÌ⣺ V5rnI\:7
1£® ÊÔÊöÀÒ°±Ëáµ°°×¼¤Ã¸ÊÜÌåµÄÐźÅͨ·£¨96£© T\c;Ra
2£® ÊÔ¾ÙÀý˵Ã÷ÐÅʹϵͳÖÐÓëϸ°ûÔöÖ³Óйصļ¤Ã¸¼°Æä¹¦ÄÜ£¨95£© cb&y8!ci~
3£® ÊÔ·ÖÎöÐźÅתµ¼£¨transduction£©µÄ¼¸Ìõͨ·µÄ¹²ÐÔÓëÌØÐÔ£¨92£© j5z, l
4£® µ°°×ÖʵÄÁ×ËữÓëÈ¥Á×ËữÔÚϸ°ûÐźÅϵͳ´«µ¼ÖеÄ×÷Óã¨93¡¢99£© 'R_U,9y`
5£® ÊÔÊöÁ×õ¥Ë®½âøC£¨PLC£©µÄ·ÖÀ༰ÔÚϸ°ûÐźÅתµ¼ÖеÄ×÷Óᣣ¨01£© 1W~-C B>
6£® ÊÔÊöϸ°û½ÓÊÜ»¯Ñ§Ðźźóµ÷½Ú»ùÒò±í´ïµÄ;¾¶£¨94£© q" wi.&|
7£® ÊÔÊöϸ°ûÖÜÆÚ¸÷½×¶ÎÖÐCyclins£CdksµÄµ÷¿Ø×÷Óã¨96£© M
Ia].S#
8£® ¾ÙÀý˵Ã÷CKIÔÚϸ°ûÔöÖ³µ÷¿ØÖеÄ×÷Óã¨96£© M)Rp+uQ
9£® ÏêÊöcyclins£cdksϵͳÔÚϸ°ûÖÜÆÚG2/M¼°M/G1¹ý¶ÈÖÐÈçºÎÊܵ½µ÷¿ØµÄ£¿ÒÑÖªÄÇЩ·Ö×Ó¿ÉÄÜÊÇcdksµÄµ×Îï¼°ÆäÔÚÁ×ËữÓëÈ¥Á×Ëữ¹ý³ÌÖжÔϸ°û½á¹¹Ó빦Äܱ仯µÄÓ°Ï죨95£© )$q<"t\#P#
10£® Cdc2ºÍcyclin»ùÒò£¨cdc13£©ÈçºÎµ÷¿ØÏ¸°ûÖÜÆÚÔËתµÄÏÖ´ú¸ÅÄ92¡¢94£© ;KQ'/nII
11£® Ϊʲô˵µ°°×ÖÊÁ×Ëữ£È¥Á×ËữºÍ·ºËؽ鵼µÄµ°°×ÖÊË®½â£¨UPP£©µÄ»¥Ïàе÷ÍÆ¶¯Ï¸°ûÖÜÆÚµÄÔËת£¿£¨01£© 6uDA{[OH
12£® ϸ°ûÔöÖ³µ÷¿ØµÄ·Ö×Ó»úÖÆ£¨00£© }SitT\%
13£® ϸ°û¹Ç¼ÜÔÚϸ°ûÔöÖ³ÖÜÆÚÖеÄ×÷Óã¨00£© }=
A6Jv(j
14£® P34cdc2µÄÐÔÖʼ°Æä×÷Óõ×ÎïÊÇʲô£¿½«ÒýÆðºÎÖÖЧӦ£¿£¨91£© $Fz/&;KX!
15£® ϸ°ûÓÐË¿·ÖÁÑÖзĴ¸Ìå΢¹ÜµÄ¶¯Á¦Ñ§±ä»¯»úÀí¼°ÆäÓëȾɫÌåÔ˶¯µÄ¹ØÏµ£¨95£© +^YV>;
16£® ΢¹ÜµÄ×é×°ÓëÈ¥×é×°ÔÚϸ°ûÓÐË¿·ÖÁѹý³ÌÖеĶ¯Ì¬±ä»¯¼°Æä×÷Óã¨92£© 3FPy
"[[
17£® ϸ°ûÓÐË¿·ÖÁѹý³ÌÖзĴ¸ÌåµÄ×é×°ÓëÈ¥×é×°µÄ¶¯Ì¬±ä»¯¼°Æä¹¦ÄÜ£¨93£© QZ{&7mc>
18£® ϸ°ûÓÐË¿·ÖÁѺóÆÚȾɫÌå·ÖÀëÇ÷ÏòÁ½¼«µÄ»úÀíÊÇÈçºÎÖ¤Ã÷µÄ£¿£¨90£© (m;P,*
19£® ÊÔÊöÖÐÐÄÁ£/¶¯Á£È¥ÔÚϸ°ûÓÐË¿·ÖÁÑÖеÄ×÷Óã¨99£© ^S ,E "Q
20£® KinetochoreÊÇÓÉÄļ¸ÖÖÖ÷Òªµ°°××é³É£¬ÓÃʲô·½·¨Ñо¿Æä¶¨Î»¡¢·Ö×ÓÁ¿¼°»úÄÜ£¿£¨90£© fH`1dU
21£® ÊÔ·Ö±ðÐðÊöÈËÀà×ÅË¿Á£ºÍ¶¯Á£µÄ»ù±¾×é³É¼«ÆäĿǰËùÖªµÄ¹¦ÄÜ£¨01£© #a#~YSnG
22£® ÊÔÊöϸ°û±à³ÌÐÔËÀÍö£¨programmed cell death£©ºÍϸ°ûµòÍö£¨apoptosis£©µÄÌØÕ÷ºÍÉúÀíѧÒâÒå¼°Æä¿ÉÄܵĻùÒòµ÷¿Ø£¬ÄãÈÏΪÑо¿µÄÖØµãÓ¦·ÅÔں䦣¿ÎªÊ²Ã´£¿£¨95£© b]RCe^E1
23£® ApoptosisÓëneerosisµÄ¼ì²âÓëÇø±ð£¨99£© p5F[( H|9
24£® ÈçºÎ¼ø±ðϸ°ûµòÍöÓ뻵ËÀ¡£Ï¸°ûµòÍöÑо¿µÄÖØÒªÒâÒåÊÇʲô£¿£¨01£© H'gPGOd
25£® ÊÔÊöunipintin£proteasen proteolytic system£¨99£© sbK0OA
26£® ÒÑÖªÓÐÄÇЩÖ÷ÒªµÄ°©»ùÒòÓëÒÖ°©»ùÒòÓëϸ°ûÖÜÆÚµÄµ÷¿ØÓйأ¿²¢¾ÙÀý˵Ã÷£¨93£© 4n3QW%#
27£® Oncogene¼°Æä²úÎïÓëϸ°ûÔöÖ³µÄ¹ØÏµ£¨91£© "vLqYc4$
28£® ¾ÙÀý˵Ã÷oncogene¡¢growth factors¼°ÊÜÌåÖ®¼äµÄÁªÏµ£¨90£© tHoFnPd\|
29£® ÊÔÊöºáÎÆ¼¡¡¢Ï¸°ûÄÚ´Öϸ˿Á½·Ö×ӵĽṹ¡¢¸÷ÖÖÖ÷Òªµ°°×³É·ÖÔÚ¼¡ÈâÊÕËõÖеÄ×÷Óᣣ¨90£© ]?``*{Zqy
30£® ÊÔÊöϸ°ûÖÊÃþÉÏĤµ°°×µÄ¼¸ÖÖÀàÐͼ°Æä¹¦ÄÜ£¨95£© q<c
).4
31£® ÊÔÊöÃâÒßѧ¼¼ÊõÔÚϸ°ûÉúÎïѧÑо¿ÖеÄÓ¦Óã¨92£© nt;A7pI`
32£® ͬԴºÐµÄ·¢ÏÖ¼°ÆäÔÚÉúÎïÖеÄÖØÒªÒâÒ壨92£© *qOo,e
33£® ÈçÒÑ֪ijһ»ùÒòƬ¶ÎÐòÁкÍÒÑ»ñµÃijһµ¥¿Ë¡¿¹ÌåÓ¦ÓúÎÖÖ¼¼Êõ·Ïߵõ½ËüµÄcDNA¿Ë¡£¨94£© d0-}Xl
34£® ¾ÙÀý˵Ã÷ÃâÒßÓ«¹âFISH¡¢ÃâÒߵ羵ÖîÏî¼¼ÊõµÄ»ù±¾ÔÀí¼°ÆäÔÚϸ°ûÉúÎïѧÑо¿Öеĸ÷½â¾öʲôÎÊÌ⣨94£© nWXI*%m5
35£® ÄãµÄ˶ʿÂÛÎÄÌá³öÁËʲôÎÊÌ⣿ÈçºÎ½â¾öµÄ£¿½áÂÛÊÇʲô£¿£¨96¡¢94¡¢00£©